I don't thin it infringes on the patent, as the silencing mechanism still involves RNA, not the ssDNA that CYGX has. The use of DNA to produce RNA is nothing new, the new thing about the CYGX work is the enabling of ssDNA production
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.